Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inhibitor Therapeutics, Inc. | Director | Common Stock | 80.4K | Apr 1, 2024 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Director | Nonqualified Stock Option (right to buy) | 25K | Mar 25, 2024 | Direct | ||
Telomir Pharmaceuticals, Inc. | Director | Incentive Stock Options (right to buy) | 25K | Aug 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Aug 29, 2024 | Director |
INTI | Inhibitor Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Director |
TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Nov 14, 2023 | 0 | $0 | 3 | Nov 20, 2023 | Director |